A global network promoting objective and open debate on drug policy
This is the first study to demonstrate that impressive reductions in HCV incidence can be achieved among PWID over a relatively short time period through high coverage of a combination of interventions.
Implementation of comprehensive harm reduction policies has achieved impressive reductions in incidence of hepatitis C virus (HCV) infections among people who inject drugs (PWID) in Scotland, research publish in PLOS ONE shows.
Stop AIDS commends the UK Department for International Development on its commitments to address HIV among key populations in developing countries, and reviews areas where DFID should take further action.
This document develops core arguments for why people who inject drugs should be included in national treatment guidelines and programmes for chronic HCV infection – from both public health and human rights perspectives.